4.7 Article

Diverse intracellular pathogens activate type III interferon expression from peroxisomes

期刊

NATURE IMMUNOLOGY
卷 15, 期 8, 页码 717-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2915

关键词

-

资金

  1. US National Institutes of Health [AI093589, AI072955, P30 DK34854, CA159132]
  2. Burroughs Wellcome Fund
  3. Crohn's and Colitis Foundation of America
  4. Agence National de la Recherche (ANR project Mitopatho)
  5. Erwin Schrodinger Fellowship of the Austrian Science Fund (FWF)
  6. Herchel Smith Graduate Fellowship Program
  7. Massachusetts Institute of Technology-Boston Children's Hospital Collaborative grant
  8. European Research Council Advanced Grant [233348]
  9. Howard Hughes Medical Institute

向作者/读者索取更多资源

Type I interferon responses are considered the primary means by which viral infections are controlled in mammals. Despite this view, several pathogens activate antiviral responses in the absence of type I interferons. The mechanisms controlling type I interferon-independent responses are undefined. We found that RIG-I like receptors (RLRs) induce type III interferon expression in a variety of human cell types, and identified factors that differentially regulate expression of type I and type III interferons. We identified peroxisomes as a primary site of initiation of type III interferon expression, and revealed that the process of intestinal epithelial cell differentiation upregulates peroxisome biogenesis and promotes robust type III interferon responses in human cells. These findings highlight the importance of different intracellular organelles in specific innate immune responses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据